Cutting Edge Spine, a leader in the development and commercialization of bioactive spinal solutions, today announced the 510(K) clearance and commercial launch of the latest addition to its [...]
The commercialization of the EVOL-SI system addresses the needs of orthopedic surgeons and neurosurgeons seeking superior clinical outcomes following sacral-iliac surgery. Waxhaw, NC August 20, [...]
Cutting Edge Spine, a US leader in the development and commercialization of bio-active technologies for the spine, today announced the 510(k) clearance and commercial launch of it’s latest [...]
Cutting Edge Spine, a technology driven developer and marketer of highly differentiated implant systems, announced that the US Food and Drug Administration has cleared the EVOS-ha, a [...]
Founded in 2009, CES is a privately owned medical device organization, headquartered in North Carolina, dedicated to developing and distributing new generation spinal technologies...